Acquisition Of Prostiva Radio Frequency Therapy (Pro-Forma Financial Information) (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Acquisition Of Prostiva Radio Frequency Therapy [Abstract]
Pro forma net revenue	$ 18,283	$ 23,523
Pro forma net loss	$ (4,960)	$ (2,862)
Pro forma net loss per share (basic)	$ (0.34)	$ (0.20)
Pro forma net loss per share (diluted)	$ (0.34)	$ (0.20)